• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number UNK SUPERA
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problems Ischemia (1942); Thrombosis/Thrombus (4440)
Event Date 01/01/2023
Event Type  Injury  
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record of the reported lot could not be conducted because the part and lot number was not provided.Reportedly, it was noted the vessel diameter is 9mm and the supera stent is 6mm.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.However, the treatments appears to be related to the operational context of the procedure as thrombolytic therapy and angioplasty was preformed.It should be noted that the supera peripheral stent system instructions for use states: the stent sizes are labeled based on the outer stent diameter.A stent should initially be chosen such that its labeled diameter matches the reference vessel diameter (rvd) proximal and distal to the lesion.Final stent selection should be confirmed after lesion pre-dilation: if possible, the stent diameter should match the prepared lesion diameter 1:1.Choosing a labeled diameter to match the reference vessel diameter, then appropriately preparing the vessel to match that stent¿s diameter will result in a stent that is properly sized to the vessel.The deviation of the instructions for use likely contributed to the reported difficulties.There is no indication of a product quality issue with respect to manufacture, design or labeling.Dates estimated literature attachment: article title: "using undersized supera in the superficial femoral artery as a coil.".
 
Event Description
During a presentation of a case regarding a 71 year old male patient that was complaining of claudication in the right leg was noted to have a total occlusion of the proximal superficial femoral artery (sfa).Percutaneous transluminal angioplasty and atherectomy was preformed with a non-abbott catheter.A 6.0x12mm supera stent was deployed in the right sfa.The patient present to the hospital with acute right leg ischemia on the same day and thrombolytic therapy and angioplasty was preformed.It was noted the vessel diameter is 9mm and the supera stent is 6mm.There was no adverse patient sequela and no clinically significant delay reported.One week later, the patient was re-admitted with acute right leg ischemia due to thrombosis of the supera stent.Patient was referred for femoral popliteal artery bypass surgery.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17242739
MDR Text Key318240674
Report Number2024168-2023-07015
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 06/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK SUPERA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/06/2023
Initial Date FDA Received06/30/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability; Hospitalization; Required Intervention;
Patient Age71 YR
Patient SexMale
-
-